83Indexed trials
Market Rank #30 · Evidence Tier A
Argentina
Neuroscience Intelligence
Argentina neuroscience intelligence: 83 indexed trials, 10 institutions, research score 29.26.
29Recruiting
10Research institutions
29.3Research score
Evidence profile
41Sponsors
17Disease areas
0Institution works
0Institution citations
Model signals
Opportunity 29 · ML priority 29 · Confidence 85 · Evidence 29.3
These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.
Leading disease areas
alzheimers19trials
parkinsons10trials
epilepsy8trials
schizophrenia6trials
depression4trials
other_neurology3trials
multiple_sclerosis3trials
neuromuscular3trials
als2trials
migraine_headache2trials
Leading indexed sponsors
Hoffmann-La Roche11trials
Merck Sharp & Dohme LLC9trials
Pfizer5trials
Novartis Pharmaceuticals4trials
Novo Nordisk A/S4trials
Eli Lilly and Company4trials
GlaxoSmithKline4trials
Washington University School of Medicine3trials
Bayer2trials
Amgen2trials